Sherman Darren 4
4 · Orchestra BioMed Holdings, Inc. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Orchestra BioMed (OBIO) President Darren Sherman Receives Award of 34,974 Shares
What Happened
Darren Sherman, President and Chief Operating Officer of Orchestra BioMed (OBIO), was credited with 34,974 shares as an award/derivative acquisition on January 28, 2026. The shares are reported at $0.00 (no cash paid), reflecting the vesting of a performance stock option granted April 23, 2025. This was an award/vesting event — not an open-market purchase or sale.
Key Details
- Transaction date: 2026-01-28; Filing date: 2026-02-06 (filed 9 days after the transaction). Form 4s are generally due within 2 business days, so this filing appears late.
- Transaction type/code: A = Grant, award or other acquisition (derivative security) at $0.00.
- Shares acquired: 34,974 shares (derivative award). Total cash value reported: $0.
- Shares owned after transaction: Not disclosed in the provided filing.
- Footnotes:
- F1: The filing states this date represents the vesting of a performance stock option granted on April 23, 2025.
- F2: The underlying option has a multi-year vesting schedule: 25% on April 23, 2026 (Vesting Commencement Date) with the remaining 75% vesting in equal quarterly installments over the following three years.
Context
This was a vesting/award of a derivative (performance stock option) rather than a market trade. That means Sherman received shares because of a compensation award or performance vesting; no sale or cash purchase occurred. The footnotes describe the original grant date and a longer-term vesting schedule, indicating additional vesting events may occur in future periods.
Insider Transaction Report
- Award
Stock Option
[F1][F2]2026-01-28+34,974→ 34,974 totalExercise: $2.85Exp: 2035-04-23→ Common Stock (34,974 underlying)
Footnotes (2)
- [F1]This date represents the date of vesting of a performance stock option granted on April 23, 2025.
- [F2]The stock option vests over a four-year period as follows: 25% on the April 23, 2026 (the "Vesting Commencement Date") with the remaining 75% vesting in equal installments every three months thereafter on the same day of the month as the Vesting Commencement Date over a three-year period, commencing in the third month after the Vesting Commencement Date.